Japan Medical & Health Tourism Center (JMHC) is a medical coordinator established by the JTB Group, Japan's largest travel agency.

Facility Details

View an overview of the medical facility, affiliated physicians, and available programs in one place.

  • 治療
  • 免疫療法
  • 再生医療
  • 幹細胞治療
  • 膠原病
  • 慢性疼痛

KYB Clinic

Stem cell therapy for autoimmune diseases, including collagen diseases such as rheumatoid arthritis and systemic lupus erythematosus.

We, at KYB Clinic, focus on stem cell therapy for autoimmune and chronic inflammatory diseases, especially rheumatoid arthritis and collagen diseases. We have active rheumatologists and collagen disease physicians on staff, and based on their clinical experience and knowledge at university hospitals, we provide the best care tailored to each individual patient. In addition, in cooperation with nearby medical institutions, we have available state-of-the-art medical testing facilities such as CT and ultrasonograph. Our clinic will comprehensively analyse the patient's blood samples and imaging data to optimise the effectiveness of treatment.

Location
〒107-0052
6F Watanabe Shoji Akasaka Bldg. 2-5-7 Akasaka, Minato-ku, Tokyo
Facility Overview
3 minutes' walk from Tameike-Sanno Station, 4 minutes' walk from Akasaka Station
Specialty
Rheumatoid arthritis, collagen diseases, autoimmune diseases, chronic pain
Stem cell therapy in the above diseases

Available Programs

  • Adipose-derived mesenchymal stem cell therapy for autoimmune diseases such as rheumatoid arthritis

    The program will focus on the treatment of autoimmune diseases and will utilize the patient's own adipose-derived mesenchymal stem cells. The stem cells, administered via intravenous infusion, release substances that suppress inflammation and may reduce the need for conventional immunosuppressive drugs and steroids. This will allow us to establish a more efficient treatment with fewer side effects.

    ① Collect fat from the abdomen and thighs and send to a stem cell culture facility ② After about one month, the infusion is ready. ③ Although the protocol varies slightly depending on the disease, basically, stem cells are infused three to four times a year. ④ Patients with high disease activity may receive an infusion of umbilical cord-derived stem cell supernatant solution between infusions. Target diseases: Rheumatoid arthritis, other collagen diseases, inflammatory bowel diseases such as ulcerative colitis, other autoimmune diseases (including type 1 diabetes), chronic inflammatory pain diseases.

    View Details